Apolipoprotein E Genotype e2: Neuroprotection and Its Limits per Hyun Kim, Hyun Kim, Davangere P. Devanand, Davangere P. Devanand, Davangere P. Devanand, Scott Carlson, Terry E. Goldberg, Terry E. Goldberg, Terry E. Goldberg

Obtenir text complet

Advancing Computerized Cognitive Training for MCI and Alzheimer's Disease in a Pandemic and Post-pandemic World per Kaylee A. Bodner, Terry E. Goldberg, Terry E. Goldberg, D. P. Devanand, D. P. Devanand, P. Murali Doraiswamy

Obtenir text complet

Efficacy of an online course in developing competency for prescribing balanced diet by medical students: A non - inferiority trial per Zinia T Nujum, P Devanand, G Remya, U Anuja

Obtenir text complet

Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies per Terry E. Goldberg, Edward D. Huey, D. P. Devanand

Obtenir text complet

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease per Jeffrey N. Motter, Xinhua Liu, Min Qian, Hannah R. Cohen, Davangere P. Devanand

Obtenir text complet

Olfaction and neurocognition after COVID-19: a scoping review per Brandon J. Vilarello, Patricia T. Jacobson, Jeremy P. Tervo, Nicholas A. Waring, David A. Gudis, David A. Gudis, Terry E. Goldberg, D. P. Devanand, D. P. Devanand, Jonathan B. Overdevest, Jonathan B. Overdevest

Obtenir text complet

Models of depressive pseudoamnestic disorder per Jongwoo Choi, Seonjoo Lee, Jeffrey N. Motter, Hyun Kim, Howard Andrews, P. Murali Doraiswamy, D. P. Devanand, Terry E. Goldberg

Obtenir text complet

The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode per Harold A. Sackeim, Joan Prudic, D.P. Devanand, Mitchell S. Nobler, Roger F. Haskett, Benoit H. Mulsant, Peter B. Rosenquist, William V. McCall

Obtenir text complet

Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment per Daniel C. Javitt, Antigona Martinez, Pejman Sehatpour, Anna Beloborodova, Christian Habeck, Yunglin Gazes, Dalton Bermudez, Qolamreza R. Razlighi, D. P. Devanand, Yaakov Stern

Obtenir text complet

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population. per Yian Gu, Qolamreza R Razlighi, Laura B Zahodne, Sarah C Janicki, Masanori Ichise, Jennifer J Manly, D P Devanand, Adam M Brickman, Nicole Schupf, Richard Mayeux, Yaakov Stern

Obtenir text complet

Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. per Jonathan B Overdevest, Alexandria L Irace, Valeria Mazzanti, Eun Jeong Oh, Paule V Joseph, Davangere P Devanand, Zachary C Bitan, Eldad A Hod, David A Gudis, Codruta Chiuzan

Obtenir text complet

Depression, Anxiety, and Neuropsychiatric Symptom Burden in a Longitudinal Cohort with Persistent Psychophysical Post-COVID Olfactory Dysfunction per Tiana M. Saak, Jeremy P. Tervo, Brandon J. Vilarello, Patricia T. Jacobson, Francesco F. Caruana, Matthew D. A. Spence, Liam W. Gallagher, David A. Gudis, Jeffrey N. Motter, Davangere P. Devanand, Jonathan B. Overdevest

Obtenir text complet

Deep learning improves utility of tau PET in the study of Alzheimer's disease per James Zou, David Park, Aubrey Johnson, Xinyang Feng, Michelle Pardo, Jeanelle France, Zeljko Tomljanovic, Adam M. Brickman, Devangere P. Devanand, José A. Luchsinger, William C. Kreisl, Frank A. Provenzano, for the Alzheimer's Disease Neuroimaging Initiative

Obtenir text complet

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial per Howard Andrews, D P Devanand, William C Kreisl, Qolamreza Razlighi, Anne Gershon, Yaakov Stern, Akiva Mintz, Thomas Wisniewski, Edward Acosta, Julianna Pollina, Mariasofia Katsikoumbas, Karen L Bell, Gregory H Pelton, Deborah Deliyannides, K M Prasad

Obtenir text complet

Recovery rates of persistent post‐COVID‐19 olfactory dysfunction using psychophysical assessment: A longitudinal cohort study per Jeremy P. Tervo, Patricia T. Jacobson, Brandon J. Vilarello, Tiana M. Saak, Francesco F. Caruana, Liam W. Gallagher, Joseph B. Gary, David A. Gudis, Paule V. Joseph, D.P. Devanand, Terry E. Goldberg, Jonathan B. Overdevest

Obtenir text complet

Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness per Seyed Hani Hojjati, Tracy A. Butler, Gloria C. Chiang, Christian Habeck, Arindam RoyChoudhury, Farnia Feiz, Jacob Shteingart, Siddharth Nayak, Sindy Ozoria, Antonio Fernández, Yaakov Stern, José A. Luchsinger, Davangere P. Devanand, Qolamreza R. Razlighi

Obtenir text complet

Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. per Lea T Drye, David Spragg, D P Devanand, Constantine Frangakis, Christopher Marano, Curtis L Meinert, Jacobo E Mintzer, Cynthia A Munro, Gregory Pelton, Bruce G Pollock, Anton P Porsteinsson, Peter V Rabins, Paul B Rosenberg, Lon S Schneider, David M Shade, Daniel Weintraub, Jerome Yesavage, Constantine G Lyketsos, CitAD Research Group

Obtenir text complet

Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET per Joanna L. Shuping, Dawn C. Matthews, Katarzyna Adamczuk, David Scott, Christopher C. Rowe, William C. Kreisl, Sterling C. Johnson, Ana S. Lukic, Keith A. Johnson, Pedro Rosa‐Neto, Randolph D. Andrews, Koen Van Laere, Lindsay Cordes, Larry Ward, Claire L. Wilde, Jerome Barakos, Derk D. Purcell, Davangere P. Devanand, Yaakov Stern, Jose A. Luchsinger, Cyrille Sur, Julie C. Price, Adam M. Brickman, William E. Klunk, Adam L. Boxer, Sulantha S. Mathotaarachchi, Patrick J. Lao, Jeffrey L. Evelhoch

Obtenir text complet